One-step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock-in mice.
Ying-Cing LinSimone PecettaJon M SteichenSven KratochvilEleonora MelziJohan ArnoldStephanie K DouganLin WuKathrin H KirschUsha NairWilliam R SchiefFacundo D BatistaPublished in: The EMBO journal (2018)
Here, we describe a one-step, in vivo CRISPR/Cas9 nuclease-mediated strategy to generate knock-in mice. We produced knock-in (KI) mice wherein a 1.9-kb DNA fragment bearing a pre-arranged human B-cell receptor heavy chain was recombined into the native murine immunoglobulin locus. Our methodology relies on Cas9 nuclease-induced double-stranded breaks directed by two sgRNAs to occur within the specific target locus of fertilized oocytes. These double-stranded breaks are subsequently repaired via homology-directed repair by a plasmid-borne template containing the pre-arranged human immunoglobulin heavy chain. To validate our knock-in mouse model, we examined the expression of the KI immunoglobulin heavy chains by following B-cell development and performing single B-cell receptor sequencing. We optimized this strategy to generate immunoglobulin KI mice in a short amount of time with a high frequency of homologous recombination (30-50%). In the future, we envision that such knock-in mice will provide much needed vaccination models to evaluate immunoresponses against immunogens specific for various infectious diseases.
Keyphrases
- crispr cas
- genome editing
- high frequency
- high fat diet induced
- endothelial cells
- binding protein
- mouse model
- squamous cell carcinoma
- infectious diseases
- poor prognosis
- dna damage
- escherichia coli
- radiation therapy
- pluripotent stem cells
- insulin resistance
- transcranial magnetic stimulation
- neoadjuvant chemotherapy
- high glucose
- mass spectrometry
- dna repair
- induced pluripotent stem cells
- wild type
- long non coding rna
- oxidative stress
- rectal cancer
- high resolution
- cell free
- sensitive detection